A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
Status:
Recruiting
Trial end date:
2026-07-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV)
of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.